...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Sabizabulin - mCRPC- used now for Covid 19.

Interesting read,,,,small enrollment and the short period of time for the C19 Plll trial. Share price has sky rocketed up!!!

https://www.onclive.com/view/novel-compound-looks-to-shake-up-mcrpc-treatment-landscape

 

VERU Inc.  

Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy

April 11, 2022 06:30 ET | Source: Veru Inc.

Share
New Message
Please login to post a reply